Brief: OncoCyte Reports First Quarter 2022 Financial Results
11/05/2022 21:54
May 11 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.11
* Q1 REVENUE $1.4 MILLION
Source text for Eikon: ID:nGNX2g7JLd
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission